On October 28, BASF announced that sales for the third quarter of 2026 were 16.4 billion euros, up 14% year on year; profit before interest, tax, depreciation and amortization before special project adjustments was 1.6 billion euros, up 15% year on year; and net profit was 155 million euros, down 9.9% year on year. Driven by growth in core businesses such as chemicals, materials, nutrition and nursing, the company raised its 2026 adjusted EBITDA forecast from 6.9 billion to 7.7 billion euros to 7.4 billion to 7.8 billion euros. The company expects free cash flow of 1.5 billion to 2.3 billion euros for the full year, maintaining previous forecasts.

On October 28, BASF announced that sales for the third quarter of 2026 were 16.4 billion euros, up 14% year on year; profit before interest, tax, depreciation and amortization before special project adjustments was 1.6 billion euros, up 15% year on year; and net profit was 155 million euros, down 9.9% year on year. Driven by growth in core businesses such as chemicals, materials, nutrition and nursing, the company raised its 2026 adjusted EBITDA forecast from 6.9 billion to 7.7 billion euros to 7.4 billion to 7.8 billion euros. The company expects free cash flow of 1.5 billion to 2.3 billion euros for the full year, maintaining previous forecasts.